Ixekizumab Provides Sustained Improvement in Signs and Symptoms in Patients with Active Psoriatic Arthritis: Two-Year Results from a Phase 3 Trial

Helliwell, P, Lespessailles, E, Shuler, C et al. (4 more authors) (2018) Ixekizumab Provides Sustained Improvement in Signs and Symptoms in Patients with Active Psoriatic Arthritis: Two-Year Results from a Phase 3 Trial. In: Journal of Rheumatology. 73rd Annual Meeting of The Canadian-Rheumatology-Association (CRA), 21-24 Feb 2018, Vancouver, Canada. Journal of Rheumatology Publishing Co., Ltd. , pp. 998-999.

Metadata

Authors/Creators:
  • Helliwell, P
  • Lespessailles, E
  • Shuler, C
  • Mallbris, L
  • Erickson, J
  • Fleischmann, R
  • Gladman, D
Copyright, Publisher and Additional Information: © 2018, Journal of Rheumatology Publishing Co., Ltd. This is an author produced version of an abstract published in Journal of Rheumatology. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 1 July 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Sep 2018 13:43
Last Modified: 01 Jul 2019 00:44
Status: Published
Publisher: Journal of Rheumatology Publishing Co., Ltd.
Related URLs:

Share / Export